Medicure Financial Statements From 2010 to 2024
| MCUJF Stock | USD 0.70 0.02 2.94% |
Check Medicure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicure's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medicure financial statements analysis is a perfect complement when working with Medicure Valuation or Volatility modules.
Medicure |
Medicure Company Return On Asset Analysis
Medicure's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medicure Return On Asset | 0.021 |
Most of Medicure's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medicure has a Return On Asset of 0.021. This is 100.24% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 115.0% lower than that of the firm.
Medicure Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicure competition to find correlations between indicators driving Medicure's intrinsic value. More Info.Medicure is considered to be number one stock in return on equity category among its peers. It is regarded third in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicure is roughly 7.06 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.About Medicure Financial Statements
Medicure stakeholders use historical fundamental indicators, such as Medicure's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medicure investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medicure's assets and liabilities are reflected in the revenues and expenses on Medicure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medicure. Please read more on our technical analysis and fundamental analysis pages.
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.